Details
- Manufacturer
- Merck (Schweiz) AG
- ATC code
- G03GA07
- Status
- 9 abgeschlossen
- Reported since
- 43 days
- First report
- 23.03.2023
- Active substance
- lutropinum alfa
- Swissmedic no.
- 5543001
- Public price (PPUB)
- CHF 60.70
- Ex-factory price (PEXF)
- CHF 40.70
- Product information (AIPS)
- swissmedicinfo.ch →
Overview
LUVERIS Trockensub 75 IE c Solv Durchstf is a medication by Merck (Schweiz) AG containing the active substance lutropinum alfa (ATC code G03GA07). This entry is marked as resolved — the documented shortage lasted 43 days. This is the only product approved in Switzerland with this active substance.
Available alternatives
No alternatives with the same active substance are currently available.
Composition
Praeparatio cryodesiccata: lutropinum alfa 3.7 µg, saccharum, methioninum, polysorbatum 20, dinatrii phosphas dihydricus, natrii dihydrogenophosphas monohydricus, acidum phosphoricum q.s. ad pH, natrii hydroxidum q.s. ad pH, pro vitro corresp. natrium 0.219 mg. Solvens: aqua ad iniectabile 1 ml.
Frequently asked questions
What can I do if LUVERIS Trockensub 75 IE c Solv Durchstf is unavailable?▾
Contact your pharmacy or treating physician. Substitution with a product containing the same active substance (lutropinum alfa) is often possible. Available alternatives are listed above on this page.
What alternatives exist for LUVERIS Trockensub 75 IE c Solv Durchstf?▾
Available alternatives with the same active substance are listed above. lutropinum alfa is the underlying active substance — pharmacies can dispense a generic or alternative brand after consulting with the doctor.
When will LUVERIS Trockensub 75 IE c Solv Durchstf be available again?▾
The expected delivery date — if communicated by the manufacturer — is shown in the detail section on this page. Shortages in this active-substance class typically last several weeks in Switzerland. Only the manufacturer can provide a binding forecast.
Why is LUVERIS Trockensub 75 IE c Solv Durchstf unavailable?▾
Common reasons include manufacturing problems, active-substance shortages, quality issues, or a planned withdrawal from the Swiss market. More detailed background — when disclosed by the manufacturer — is shown in the detail section above.
Where do I report a shortage of LUVERIS Trockensub 75 IE c Solv Durchstf?▾
Shortages are officially reported to drugshortage.ch (by manufacturers and pharmacies). Patients and treating physicians can escalate the shortage through their pharmacy — which has direct access to the reporting pipeline.
Source: drugshortage.ch · no warranty of completeness